These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum. Tredger JM; Brown NW; Dhawan A Drugs; 2008; 68(10):1385-414. PubMed ID: 18578558 [TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients. Baczkowska T; Durlik M Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814 [TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitor sparing in renal transplantation. Ekberg H Transplantation; 2008 Sep; 86(6):761-7. PubMed ID: 18813097 [TBL] [Abstract][Full Text] [Related]
11. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy. Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing late concentration-controlled calcineurin inhibitor or mycophenolate mofetil withdrawal. Mourer JS; Hartigh Jd; van Zwet EW; Mallat MJ; Dubbeld J; de Fijter JW Transplantation; 2012 May; 93(9):887-94. PubMed ID: 22538450 [TBL] [Abstract][Full Text] [Related]
13. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children. Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitor avoidance and withdrawal for kidney transplantation: a systematic review and meta-analysis of randomized controlled trials. Yan HL; Zong HT; Cui YS; Li N; Zhang Y Transplant Proc; 2014 Jun; 46(5):1302-13. PubMed ID: 24935293 [TBL] [Abstract][Full Text] [Related]
15. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. Mourer JS; de Koning EJ; van Zwet EW; Mallat MJ; Rabelink TJ; de Fijter JW Transplantation; 2013 Jul; 96(1):49-57. PubMed ID: 23715049 [TBL] [Abstract][Full Text] [Related]
16. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review. Ponticelli C; Scolari MP Transplant Proc; 2010; 42(6):2205-8. PubMed ID: 20692445 [TBL] [Abstract][Full Text] [Related]
18. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview. Höcker B; Tönshoff B Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724 [TBL] [Abstract][Full Text] [Related]
19. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation. Helal I; Chan L Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737 [TBL] [Abstract][Full Text] [Related]